This page shows the 2D-LC Method database that has been established as part of the collaboration between the University of Amsterdam and Gustavus Adolphus College.
The database comprises all methods published from 1978 until 2022.
The method reference is formatted as:
FIRST_DIMENSION, INTERFACE, SECOND_DIMENSION, DETECTION (COUPLING, MODULATION_TYPE)
| Application | Category | Method | Reference |
|---|---|---|---|
| Antibody-drug conjugates | Biopharma | HIC-RPLC-MS (N,P) | Gilroy et al. (2017) |
| Antibody-drug conjugates | Biopharma | SEC-RPLC-UV-vis (N,P) | Li et al. (2016) |
| Antibody-drug conjugates | Biopharma | RPLC-RPLC-UV-vis (N,P) | Venkatramani et al. (2017) |
| Antibody-drug conjugates | Biopharma | SEC-RPLC-UV-vis (N,P) | Goyon et al. (2018) |
| Antibody-drug conjugates | Biopharma | RPLC×RPLC-MS, UV-vis (N,P) | Sandra et al. (2016) |
| Antibody-drug conjugates | Biopharma | RPLC-RPLC-MS, UV-vis (N,P) | Sandra et al. (2016) |
| Antibody-drug conjugates | Biopharma | HIC×RPLC-MS, UV-vis (N,P) | Sarrut et al. (2016) |
| Antibody-drug conjugates | Biopharma | HIC×SEC-MS (N,P) | Ehkirch et al. (2018) |
| Antibody-drug conjugates (free species) | Biopharma | SEC-RPLC-UV-vis (N,P) | Li et al. (2016) |
| Antibody-drug conjugates (free species) | Biopharma | MM-RPLC-MS (N,P) | Birdsall et al. (2016) |
| Biopharmaceuticals (impurities) | Biopharma | RPLC-RPLC-MS (N,P) | Petersson et al. (2016) |
| Bovine insulin (degradants) | Biopharma | RPLC-RPLC-UV-vis (N,A) | Stoll et al. (2017) |
| Monoclonal antibodies | Biopharma | Affinity-SEC-UV-vis (N,P) | Williams et al. (2017) |
| Monoclonal antibodies | Biopharma | WCX-SEC-UV-vis (N,P) | An et al. (2017) |
| Monoclonal antibodies | Biopharma | SCX×RPLC-MS (N,P) | Sorensen et al. (2016) |
| Monoclonal antibodies | Biopharma | SCX-RPLC-MS (N,P) | Gstöttner et al. (2018) |
| Oligonucleotides (impurities) | Biopharma | SEC-IP-RPLC-MS (N,S) | Roussis et al. (2018) |
| Oligonucleotides (impurities) | Biopharma | RPLC×IP-RPLC-MS (N,S) | Roussis et al. (2018) |
| Oligonucleotides (impurities) | Biopharma | SAX-IP-RPLC-MS (N,S) | Roussis et al. (2018) |
| Oligonucleotides (impurities) | Biopharma | IP-RPLC×IP-RPLC-MS (N,S) | Roussis et al. (2018) |
| Therapeutic antibodies | Biopharma | IEX-RPLC-MS (N,P) | Bathke et al. (2018) |
| Therapeutic antibodies | Biopharma | HILIC×RPLC-MS (N,A) | Stoll et al. (2018) |
| Wastewater effluent (AChE inhib.) | Environmental | RPLC×RPLC-MS, UV-vis (N,P) | Ouyang et al. (2016) |
| Emerging contaminants | Environmental | RPLC×RPLC-MS (N,P) | Leonhardt (2016) |
| Polycyclic aromatics | Environmental | RPLC×RPLC-UV-vis (N,P) | Graesbøll et al. (2017) |
| Black chokeberries pomace | Food | HILIC×RPLC-MS, UV-vis (N,P) | Brazdauskas et al. (2016) |
| Overripe fruits (carotenoids) | Food | NPLC×RPLC-MS, UV-vis (N,P) | Cacciola et al. (2016) |
| Hop cones, pellet extracts | Food | RPLC×RPLC-MS, UV-vis (N,P) | Sommella et al. (2018) |
| Hop cones, pellet extracts | Food | HILIC×RPLC-MS, UV-vis (N,P) | Sommella et al. (2018) |
| Soybean (Kunitz Trypsin Inhibitor) | Food | WAX-SEC-MS (F,M) | Zhou et al. (2017) |
| Corn oil (Triacylglycerols) | Food | AgLC×RPLC-MS (N,P) | Navarro-Reig et al. (2016) |
| Tea, Grape seed, red wine (extracts) | Food | HILIC×RPLC-IMS-MS (N,P) | Venter et al. (2018) |
| Wine (polyphenols and contaminants) | Food | RPLC×RPLC-MS, UV-vis (N,P) | Donato et al. (2016) |
| Acyl-Coenzyme A (mouse liver) | Metabolites | RPLC-RPLC-MS (N,P) | Wang et al. (2017) |
| Amino acids (of gramicidin, bacitracin) | Metabolites | Chiral×Chiral-UV-vis (N,P) | Woiwode et al. (2018) |
| Amino acids (tea, amino acids) | Metabolites | RPLC-Chiral-UV-vis (F,M) | Wang et al. (2017) |
| Antioxidants (Malus hupehensis) | Metabolites | HILIC-RPLC-MS, UV-vis (F,M) | Liu et al. (2018) |
| Breast milk (fluoxetine, norfluoxetine) | Metabolites | SEC-Chiral-MS (N,P) | Lopes et al. (2018) |
| Breast milk (fluoxetine, norfluoxetine) | Metabolites | SEC-RPLC-MS (N,P) | Alvim-Jr. et al. (2016) |
| Flavonoids | Metabolites | HILIC-RPLC-MS (F,M) | Yao et al. (2017) |
| Flavonoids | Metabolites | RPLC×RPLC-UV-vis (N,P) | Corgier et al. (2016) |
| Flavonoids from licorice | Metabolites | NPLC-RPLC-MS, UV-vis (F,M) | Fan et al. (2016) |
| Furanocoumarins | Metabolites | RPLC×RPLC-UV-vis (N,P) | Cook et al. (2017) |
| Lipidomics (brain tissue) | Metabolites | HILIC-RPLC-MS (N,S) | Berkecz et al. (2018) |
| Lipidomics (human plasma) | Metabolites | NPLC-RPLC-MS (N,V) | Shen et al. (2017) |
| Lipidomics (mice serum) | Metabolites | NPLC-RPLC-MS (N,V) | Weng et al. (2016) |
| Lipidomics (rat plasma) | Metabolites | MM-RPLC-MS (F,M) | Narváez-Rivas et al. (2017) |
| Lipidomics (cyanobacteria) | Metabolites | NPLC-RPLC-MS (N,V) | Shan et al. (2016) |
| Lipidomics (human plasma) | Metabolites | RPLC×HILIC-MS (N,P) | Baglai et al. (2017) |
| Lipids (rice) | Metabolites | RPLC×HILIC-MS (N,P) | Navarro-Reig et al. (2018) |
| Metabolites (Escherichia coli) | Metabolites | RPLC×RPLC-MS, UV-vis (N,P) | Cacciola et al. (2018) |
| Metabolites (green cocoa beans) | Metabolites | HILIC×RPLC-MS, UV-vis (N,S) | Toro-Uribe et al. (2018) |
| Metabolites (licorice) | Metabolites | HILIC×RPLC-MS, UV-vis (N,P) | Montero et al. (2016) |
| Metabolites (microbial) | Metabolites | RPLC×RPLC-UV-vis (N,S) | Yan et al. (2016) |
| Metabolites (Panax notoginseng leaves) | Metabolites | HILIC×RPLC-MS, UV-vis (F,M) | Yao et al. (2018) |
| Metabolites (rice plant) | Metabolites | HILIC×RPLC-MS (N,P) | Navarro-Reig et al. (2017) |
| Metabolites (Vitamin D, human serum) | Metabolites | RPLC-RPLC-MS (N,S) | Mena-Bravo et al. (2016) |
| Metabolites and lipids (human plasma) | Metabolites | RPLC-RPLC-MS (N,P) | Wang et al. (2017) |
| Metabolomics (Glycyrrhiza glabra) | Metabolites | RPLC×RPLC-MS, UV-vis (N,P) | Wong et al. (2018) |
| Phenolic acids | Metabolites | RPLC×RPLC-UV-vis (N,O) | Fornells et al. (2018) |
| Phenolic acids and flavonoids | Metabolites | MM×RPLC-UV-vis (N,P) | Hájek et al. (2016) |
| Phenolic compounds (Grapevine canes) | Metabolites | HILIC×RPLC-MS, UV-vis (N,P) | Montero et al. (2018) |
| Plant extracts and coffee | Metabolites | RPLC-RPLC-MS (N,P) | Stephan et al. (2016) |
| Polyphenols | Metabolites | HILIC×RPLC-MS (N,S) | Sommella et al. (2017) |
| Polyphenols in red raspberry fruits shoots | Metabolites | RPLC×RPLC-MS (N,P) | Kula et al. (2016) |
| Procyanidins (cocoa) | Metabolites | HILIC×RPLC-UV-vis (N,P) | Muller et al. (2018) |
| Proteinogenic amino acids | Metabolites | RPLC-Chiral-UV-vis (N,P) | Woiwode et al. (2018) |
| Pyrrolizidine alkaloids | Metabolites | RPLC-RPLC-MS (N,P) | van de Schans et al. (2017) |
| Steroids | Metabolites | TRLC×RPLC-UV-vis (N,P) | Baert et al. (2018) |
| Testosterone (human serum) | Metabolites | RPLC-RPLC-MS (N,P) | Vamethevan et al. (2016) |
| Urine (bovine) | Metabolites | RPLC×RPLC-MS (N,S) | Baglai et al. (2018) |
| Urine (Steroids, Sulphonamides) | Metabolites | RPLC×RPLC-MS (N,P) | Blokland et al. (2018) |
| Bioactives in plant extracts | Miscellaneous | RPLC×RPLC-ELSD (N,S) | Coulerie et al. (2016) |
| Heavy-oil fractions | Miscellaneous | NA-RPLC×NA-RPLC-CAD, UV-vis (N,P) | van Beek et al. (2018) |
| Household dust and dryer lint | Miscellaneous | RPLC×RPLC-MS (N,P) | Ouyang et al. (2017) |
| Lignin phenols | Miscellaneous | RPLC×SFC-UV-vis (N,S) | Sun et al. (2018) |
| Synthetic cannabinoids | Miscellaneous | RPLC×RPLC-MS (N,P) | Eckberg et al. (2018) |
| Synthetic dyes | Miscellaneous | SAX×IP-RPLC-UV-vis (N,P) | Pirok et al. (2016) |
| Tobacco | Miscellaneous | SCX-RPLC-MS (N,S) | Shao et al. (2017) |
| Tobacco (snus) | Miscellaneous | RPLC-RPLC-MS (N,P) | Gi et al. (2017) |
| Vacuum-gas oil fraction | Miscellaneous | RPLC×RPLC-MS (N,S) | Jakobsen et al. (2017) |
| Phlorotannins in brown algae | Natural medicines | HILIC×RPLC-MS, UV-vis (N,P) | Sánchez-Camargo et al. (2016) |
| Brown seaweed | Natural medicines | HILIC×RPLC-MS, UV-vis (N,P) | Montero et al. (2016) |
| TCM (Additives) | Natural medicines | Affinity-RPLC-UV-vis (N,S) | Guo et al. (2017) |
| TCM (Dracocephalum heterophyllium) | Natural medicines | RPLC-HILIC-MS, NMR (F,M) | Dang et al. (2018) |
| TCM (U. rhynchophylla) | Natural medicines | MM-MM-UV-vis (F,M) | Wei et al. (2016) |
| TCM (Curcuma kwangsiensis) | Natural medicines | RPLC×RPLC-MS (N,P) | Zhou et al. (2018) |
| TCM (Flos Carthami, dried flowers) | Natural medicines | MM×RPLC-UV-vis (N,S) | Wang et al. (2017) |
| TCM (Gardenia jasminoides Ellis) | Natural medicines | RPLC×HILIC-MS (F,M) | Zhou et al. (2017) |
| TCM (Gegen-Qinlian Decoction) | Natural medicines | RPLC×RPLC-MS (N,P) | Qiao et al. (2016) |
| TCM (Notoginseng total saponins) | Natural medicines | HILIC×RPLC-MS (F,M) | Yang et al. (2016) |
| TCM (Oxytropis falcata) | Natural medicines | RPLC-RPLC-UV-vis (F,M) | Wang et al. (2017) |
| TCM (Salvia miltiorrhiza) | Natural medicines | HILIC×RPLC-MS (F,M) | Sun et al. (2016) |
| TCM (Salvia miltiorrhiza) | Natural medicines | RPLC×RPLC-MS (N,P) | Cao et al. (2016) |
| TCM (sapinins and alkaloids) | Natural medicines | RPLC-RPLC-MS (F,M) | Jin et al. (2018) |
| TCM (saponins in Gleditsia sinensis) | Natural medicines | RPLC×RPLC-MS (N,P) | Wang et al. (2016) |
| TCM (Sphaerophysa salsula) | Natural medicines | RPLC-HILIC-NMR,UV-vis (F,M) | Jiao et al. (2017) |
| TCM (toad skin) | Natural medicines | NPLC×RPLC-MS (F,M) | Zhang et al. (2016) |
| TCM (Tropane alkaloids) | Natural medicines | RPLC-SCX-UV-vis (N,P) | Long et al. (2018) |
| TCM (Xuebijing) | Natural medicines | RPLC-RPLC-MS, UV-vis (N,P) | Lin et al. (2018) |
| TCM (Zhibai Dihuang Granule) | Natural medicines | SCX×RPLC-MS (F,M) | Liu et al. (2018) |
| TCM (Denzhan Shenmai) | Natural medicines | RPLC×RPLC-MS (F,P) | Sheng et al. (2017) |
| TCM (Denzhan Shenmai) | Natural medicines | RPLC-Chiral-MS (N,P) | Sheng et al. (2017) |
| TCM (Ginseng powder) | Natural medicines | HILIC-RPLC-UV-vis (N,P) | Ji et al. (2016) |
| TCM (Ginkgo biloba) | Natural medicines | HILIC×RPLC-MS (F,P) | Ji et al. (2017) |
| Peptide biomarkers (rat urine) | Peptides | RPLC-RPLC-MS (F,M) | Zhang et al. (2018) |
| Peptic digests | Peptides | RPLC-MM-MS (N,S) | Saleh et al. (2016) |
| Peptides | Peptides | RPLC×RPLC-MS, UV-vis (N,P) | Sarrut et al. (2017) |
| Protein digests (plasma) | Peptides | RPLC-RPLC-MS (F,M) | Yang et al. (2018) |
| Tryptic peptides | Peptides | SCX-RPLC-MS (N,S) | Kwiatkowski et al. (2018) |
| Tryptic peptides (Cortical neurons) | Peptides | SCX×RPLC-MS (N,S) | Chuang et al. (2018) |
| Tryptic peptides (Elaeis Guineensis Jacq) | Peptides | RPLC-RPLC-MS (N,S) | Nascimento et al. (2018) |
| Tryptic peptides (Flammulina velutipes) | Peptides | RPLC-RPLC-MS (F,M) | Fang et al. (2017) |
| Tryptic peptides (human tissue, cancer) | Peptides | RPLC-RPLC-MS (N,P) | Lee et al. (2016) |
| Tryptic peptides (mitochondrial proteins) | Peptides | SCX-RPLC-MS (F,M) | Li et al. (2018) |
| Tryptic peptides (lung adenocarcinoma) | Peptides | SCX-RPLC-MS (F,M) | Li et al. (2018) |
| Tryptic peptides (proteus mirabilis) | Peptides | RPLC-RPLC-MS (F,M) | Dong et al. (2018) |
| Tryptic peptides (Salmonella bacteria) | Peptides | SCX-RPLC-MS (F,M) | Sun et al. (2018) |
| Tryptic peptides (serum) | Peptides | SCX-RPLC-MS (F,M) | Sun et al. (2017) |
| Tryptic peptides (serum) | Peptides | SCX-RPLC-MS (F,M) | Ye et al. (2017) |
| Peptides | Peptides | RPLC×SEC-UV-vis (N,P) | Xu et al. (2018) |
| Peptides | Peptides | Chiral-RPLC-FLD, MS (N,P) | Cheng et al. (2018) |
| Peptides | Peptides | Chiral-Affinity-FLD, MS (N,P) | Cheng et al. (2018) |
| Peptides | Peptides | SEC×RPLC-UV-vis (N,P) | Xu et al. (2017) |
| Peptides | Peptides | RPLC-RPLC-MS, UV-vis (N,P) | Luo et al. (2017) |
| Antibiotic drug (cefonicid sodium) | Pharmaceuticals | RPLC-RPLC-MS (N,P) | Wang et al. (2017) |
| Antibiotic residues in dairy products | Pharmaceuticals | HILIC-RPLC-MS (N,P) | Wang et al. (2017) |
| Antibiotics | Pharmaceuticals | RPLC-RPLC-MS (N,P) | Wang et al. (2017) |
| Beta-blockers in human plasma | Pharmaceuticals | SEC-RPLC-FLD (N,P) | Gonçalves et al. (2017) |
| Desonide cream | Pharmaceuticals | RPLC-RPLC-MS (N,P) | Wang et al. (2018) |
| Parental drug microdosing vehicle | Pharmaceuticals | RPLC-RPLC-MS, UV-vis (N,P) | Dai et al. (2017) |
| Pharmaceutical materials | Pharmaceuticals | RPLC-RPLC-MS, UV-vis (N,P) | Yang et al. (2017) |
| Pharmaceuticals | Pharmaceuticals | RPLC-SFC-UV-vis (N,P) | Iguiniz et al. (2018) |
| Pharmaceuticals | Pharmaceuticals | Chiral×Chiral-UV-vis (N,P) | Barhate et al. (2017) |
| Pharmaceuticals | Pharmaceuticals | RPLC-Chiral-UV-vis (N,P) | Barhate et al. (2017) |
| Pharmaceuticals | Pharmaceuticals | RPLC-SFC-MS, UV-vis (N,S) | Venkatramani et al. (2016) |
| Pharmaceuticals | Pharmaceuticals | RPLC×RPLC-MS, UV-vis (N,P) | Iguiniz et al. (2018) |
| Pharmaceuticals, Metabolites | Pharmaceuticals | RPLC-Chiral-MS (N,S) | Goel et al. (2018) |
| Therapeutic drug (in human plasma) | Pharmaceuticals | RPLC-RPLC-UV-vis (N,S) | Sheng et al. (2017) |
| Vidarabine monophosphate | Pharmaceuticals | RPLC-MM-MS (N,S) | Wang et al. (2017) |
| Vitamins | Pharmaceuticals | HILIC-RPLC-UV-vis (N,A) | Bäurer et al. (2018) |
| Oligomers (Oxidzed waxes) | Polymers | NPLC×SEC-ELSD (N,P) | Ndiripo et al. (2018) |
| Polyether polyols | Polymers | HILIC×RPLC-MS (N,P) | Groeneveld et al. (2018) |
| Polymeric nanoparticles | Polymers | HDC×SEC-UV-vis (N,S) | Pirok et al. (2017) |
| Synthetic polymers (Polystyrene/ Polybutadiene Block Copolymers) | Polymers | NA-TGIC×SEC-UV-vis (N,S) | Lee et al. (2018) |
| Synthetic polymers (Polystyrene/ Polybutadiene Block Copolymers) | Polymers | RP-TGIC×LCCC-UV-vis (N,S) | Lee et al. (2018) |
| Synthetic polymers (novolac) | Polymers | SEC×RPLC-UV-vis (N,A) | Pursch et al. (2018) |
| Synthetic polymers (branched poly (bisphenol-A-carbonate)) | Polymers | LCCC×SEC-LS, RID, UV-vis, VI (N,P) | Apel et al. (2018) |
| Synthetic polymers (HEUR) | Polymers | SEC×RPLC-ELSD (N,P) | Yang et al. (2018) |
| Synthetic polymers (non-linear) | Polymers | NPLC×SEC-LS, RID, VI (N,P) | Lee et al. (2016) |
| Synthetic polymers (poloxamers) | Polymers | LCCC×LCCC-ELSD (N,P) | Malik et al. (2016) |
| Synthetic polymers (polystyrene) | Polymers | NA-RPLC×SEC-UV-vis (N,P) | Urban et al. (2017) |
| Intact histone proteoforms | (Intact) Proteins | MM×RPLC-MS (N,S) | Gargano et al. (2018) |
| Intact proteins | (Intact) Proteins | SCX×RPLC-UV-vis (N,P) | Lynch et al. (2018) |
| Intact proteins and protein digests | (Intact) Proteins | SCX×IP-RPLC-MS, UV-vis (N,P) | Vonk et al. (2015) |
| Metaproteomics (soil) | (Intact) Proteins | SCX-RPLC-MS (N,S) | Callister et al. (2018) |
| Proteins in human plasma | (Intact) Proteins | SAX×RPLC-None (N,S) | Huang et al. (2016) |
| Ethoxylate phosphate surfactants | Surfactants | HILIC×RPLC-UV-vis (N,S) | Gargano et al. (2016) |
| Ionic surfactants | Surfactants | MM×RPLC-CAD (N,P) | Pirok et al. (2018) |
| Non-ionic surfactants in pharmaceuticals | Surfactants | HILIC×RPLC-ELSD, MS (N,P) | (2018) |
| Polymeric dispersants in detergents | Surfactants | SEC-RPLC-ELSD (N,P) | Yang et al. (2018) |
| Dye extracts | Miscellaneous | SAX×RPLC-MS, UV-vis (N,S) | Pirok et al. (2019) |
| Charged acrylic polymeric particles | Polymers | SEC×SEC-UV-vis (N,S) | Pirok et al. (2019) |
| Pharmaceutical drugs | Pharmaceuticals | RPLC×RPLC-MS, UV-vis (N,P) | Iguiniz et al. (2019) |
| Pharmaceutical drugs | Pharmaceuticals | RPLC-WAX-MS (N,P) | Long et al. (2019) |
| Phenolic compounds | Metabolites | HILIC×RPLC-UV-vis (N,P) | Jandera et al. (2019) |
| Natural phenolics in Rooibos tea, Grape seed | Food | HILIC×RPLC-MS (N,O) | Muller et al. (2019) |
| Panax ginseng root extract in saponin | Traditional Chinese medicine | RPLC×HILIC-UV-vis (N,P) | Chen et al. (2019) |
| Phenolic compounds in pomegranate | Food | RPLC×RPLC-MS, UV-vis (N,P) | Russo et al. (2019) |
| Pistacia vera L. kernel extracts | Food | RPLC×RPLC-MS (N,P) | Arena et al. (2019) |
| Prebiotic oligosaccharides | Food | HILIC×RPLC-UV-vis (N,S) | Martín-Ortiz et al. (2019) |
| Proteins in eggs | Food | SEC×RPLC-MS (N,S) | Melfi et al. (2019) |
| Branched polystyrene | Polymers | RP-TGIC×LCCC-UV-vis (N,P) | Im et al. (2006) |
| Branched polystyrene | Polymers | LCCC×SEC-UV-vis (N,P) | Im et al. (2006) |
| PS-b-PMMA diblock copolymer | Polymers | RPLC×SEC-UV-vis (N,P) | Lee et al. (2015) |
| Therapeutic antibodies (Histidine degradation) | Biopharma | SEC×HILIC-MS, UV-vis (N,P) | Wang et al. (2015) |
| Metabolites (mushroom extracts) | Food | RPLC-RPLC-UV-vis (F,M) | Pandohee et al. (2015) |
| Synthetic polymers (bimodal high-density polyethylene) | Polymers | RPLC×SEC-ELSD (N,P) | Prabhu et al. (2015) |
| TCM (ginsenosides in Panax ginseng) | Natural medicines | HILIC×RPLC-MS (F,M) | Qiu et al. (2015) |
| Lipidomics (mice serum) | Metabolites | NPLC-RPLC-MS (N,V) | Weng et al. (2015) |
| Monoclonal antibodies (rituximab) | Biopharma | CEX-RPLC-MS (N,P) | Stoll et al. (2015) |
| Carboxilic acids | Metabolites | RPLC×RPLC-UV-vis (N,P) | Stoll et al. (2015) |
| Benzophenones (transformation products) | Environmental | RPLC-BMC- (N,P) | Li et al. (2015) |
| Lipidomics | Metabolites | RPLC×HILIC-MS (N,P) | Holčapek et al. (2015) |
| TCM | Natural medicines | SCX-RPLC-MS (F,M) | Jiang et al. (2015) |
| Fish oil (Triacylglycerol) | Food | AgLC×NA-RPLC-ELSD, MS (N,O) | Beccaria et al. (2015) |
| Proteins from mouse adipose tissue | (Intact) Proteins | SCX×RPLC-MS (F,M) | Sajic et al. (2015) |
| Cannabinoids | Natural medicines | RPLC-RPLC-MS, Other (N,P) | Pandohee et al. (2015) |
| Natural polymers (carboxymethyl celluloses) | Polymers | RPLC×SEC-ELSD (N,P) | Shakun et al. (2015) |
| Metabolites (Pichia pastoris) | Metabolites | RPLC-RPLC-MS (N,P) | Ortmayr et al. (2015) |
| HBCD Isomersin PS Foam | Polymers | RPLC-RPLC-UV-vis (N,P) | Pursch et al. (2015) |
| Peptides (Saccharomyces cerevisiae digest) | Peptides | SCX×RPLC-MS (N,S) | Vonk et al. (2015) |
| Synthetic polymers (polystyrene block copolymers) | Polymers | RPLC×SEC-ELSD (N,P) | Wright et al. (2015) |
| Metabolites | Metabolites | RPLC×RPLC-MS (N,P) | Willmann et al. (2015) |
| Aflatoxins (Aspergillus sp.) | Food | RPLC-RPLC-MS (N,P) | Breidbach et al. (2015) |
| Yoghurt (food additives) | Food | RPLC-RPLC-UV-vis (N,O) | Hou et al. (2015) |
| Ramelteon (human serum) | Pharmaceuticals | RPLC-RPLC-UV-vis (N,P) | Sagirli et al. (2015) |
| Phospholipids | Food | HILIC-RPLC-MS (N,P) | Sun et al. (2015) |
| Phosphatidylcholine isomers | Food | HILIC-RPLC-MS (N,P) | Sun et al. (2014) |
| Therapeutic antibodies | Biopharma | RPLC×RPLC-MS, UV-vis (N,P) | Vanhoenacker et al. (2015) |
| Wastewater effluent (toxicants) | Environmental | RPLC×RPLC-MS, UV-vis (N,P) | Ouyang et al. (2015) |
| Peptides (from milk) | Food | RPLC×RPLC-UV-vis (N,P) | Sommella et al. (2015) |
| TCM (Tripterygium wilfordii Hook.f) | Natural medicines | RPLC×RPLC-MS (N,P) | Qu et al. (2015) |
| TCM (triterpenoid saponins) | Natural medicines | HILIC-RPLC-MS (N,O) | Wang et al. (2015) |
| TCM (Carthamus tinctorius L.) | Natural medicines | HILIC×RPLC-MS (F,M) | Yang et al. (2015) |
| TCM (Panax notoginseng saponins) | Natural medicines | RPLC-RPLC-UV-vis (N,P) | Yao et al. (2015) |
| Dairy products (Proteins and additives) | Food | RPLC-RPLC-UV-vis (N,O) | Hou et al. (2015) |
| Flavonoids and iridoid glycosides in Hedyotis diffusa | Natural medicines | RPLC×RPLC-MS, UV-vis (N,P) | Li et al. (2015) |
| Antibody-drug conjugates (free species) | Biopharma | SEC-RPLC-MS, UV-vis (N,P) | Li et al. (2015) |
| Pharmaceuticals (naproxen and degradants) | Pharmaceuticals | RPLC×RPLC-UV-vis (N,P) | Stoll et al. (2015) |
| Glycated albumin (digest) | Peptides | Affinity-RPLC-MS (N,S) | Pepaj et al. (2015) |
| Tryptic digests | Peptides | RPLC×RPLC-UV-vis (N,P) | Sarrut et al. (2015) |
| Wastewater effluent (pharmaceuticals and pesticides) | Environmental | RPLC×RPLC-MS (N,P) | Leonhardt et al. (2015) |
| TCM (bufadienolides in toad skin) | Natural medicines | NPLC×RPLC-MS (F,M) | Zhang et al. (2015) |
| TCM (antioxidants in Ginkgo biloba extract) | Natural medicines | RPLC×RPLC-UV-vis (N,P) | Guo et al. (2015) |
| TCM (Hypericum ascyron extract) | Natural medicines | RPLC-RPLC-UV-vis (N,P) | Li et al. (2015) |
| Red chili pepper (caretenoids) | Food | NPLC×RPLC-MS, UV-vis (N,P) | Mondello et al. (2014) |
| Pharmaceutical drugs | Pharmaceuticals | RPLC-RPLC-MS, UV-vis (N,P) | Venkatramani et al. (2014) |
| Vancomycin in plasma | Pharmaceuticals | RPLC-RPLC-UV-vis (N,S) | Li et al. (2014) |
| Anthocyanins in blue berries, red radish, cabbage and black beans | Food | HILIC×RPLC-MS (F,P) | Willemse et al. (2014) |
| White wine and TCM | Food | MM×RPLC-UV-vis (N,P) | Li et al. (2014) |
| Neurotransmitters | Metabolites | RPLC-RPLC-MS, Other (N,P) | Holland et al. (2014) |
| Tryptic digest (endogenous PSA) | Peptides | HILIC-RPLC-MS (N,S) | Simon et al. (2014) |
| Phosphatidylcholine isomers in cell membranes | Miscellaneous | HILIC-RPLC-MS (N,P) | Sun et al. (2014) |
| poly(styrene)-co-poly(methyl methacrylate)latex | Polymers | RPLC×SEC-UV-vis (N,P) | Schoenmakers et al. (2014) |
| Synthetic polymers (polystyrene) | Polymers | NPLC×SEC-UV-vis (N,P) | Jeong et al. (2014) |
| Synthetic polymers (polysorbate) | Polymers | MM-RPLC-UV-vis (N,P) | Li et al. (2014) |
| Bio-oil (organic acids) | Miscellaneous | RPLC×RPLC-MS (N,P) | Le Masle et al. (2014) |
| Oligonucleotides | Miscellaneous | IP-RPLC×CE-UV-vis (F,M) | Porebski (2014) |
| Milk powder (carbohydrates) | Food | RPLC-RPLC-RID (N,S) | Ma et al. (2014) |
| Sugar phosphates in yeast cells | Metabolites | SAX-RPLC-MS (N,P) | Klavins et al. (2014) |
| Polycyclic aromatic compounds | Miscellaneous | RPLC×RPLC-UV-vis (N,P) | Græsbøll et al. (2014) |
| Corn seed, Gingo Biloba and valerian root | Natural medicines | RPLC-RPLC-UV-vis (N,S) | Allen et al. (2014) |
| Polycyclic aromatic hydrocarbons | Miscellaneous | RPLC×RPLC-UV-vis (N,P) | Place et al. (2014) |
| Synthetic polymers (poly(propylene) copolymers) | Polymers | RPLC×SEC-ELSD (N,P) | Cheruthazhekatt et al. (2014) |
| Pharmaceutical drugs | Pharmaceuticals | RPLC-RPLC-UV-vis (N,P) | Shackman et al. (2014) |
| Phenolic antioxidants | Food | HILIC×RPLC-Other, UV-vis (N,P) | Kalili et al. (2014) |
| TCM (Radix et Rhizoma Asari) | Natural medicines | Affinity-RPLC-MS (N,S) | Han et al. (2014) |
| Sugarcane leaf (polyphenols) | Food | RPLC×RPLC-MS (N,P) | Leme et al. (2014) |
| TCM (P. lobata) | Natural medicines | RPLC×RPLC-MS, UV-vis (N,P) | Qiao et al. (2014) |
| Lipidomics (human plasma) | Metabolites | NPLC-RPLC-MS (N,V) | Li et al. (2014) |
| Milk powder (flavonoids) | Food | RPLC-RPLC-UV-vis (N,S) | Ma et al. (2014) |
| Fatty alcohol ethoxylates | Surfactants | RPLC-RPLC-UV-vis (N,P) | Escrig-Doménech et al. (2014) |
| Brown algae (phlorotannins) | Food | HILIC×RPLC-MS, UV-vis (N,P) | Montero et al. (2014) |
| Synthetic polymers (ethylene/1‚Äêoctene copolymers) | Polymers | RPLC×SEC-ELSD (N,P) | Mekab et al. (2014) |
| Lipidomics (human plasma) | Metabolites | HILIC×RPLC-MS (N,O) | Wang et al. (2013) |
| Furanocoumarins | Metabolites | RPLC×RPLC-UV-vis (N,P) | Tran et al. (2013) |
| Red wine | Food | MM×RPLC-UV-vis (N,P) | Matos et al. (2013) |
| Wastewater effluent (contaminants) | Environmental | RPLC×RPLC-MS (N,P) | Haun et al. (2013) |
| Apples (phenolic compounds) | Food | HILIC×RPLC-MS, UV-vis (N,P) | Montero et al. (2013) |
| Synthetic polymers (tacticity of Poly(Methyl Methacrylates)) | Polymers | RPLC×SEC-ELSD (N,P) | Maiko et al. (2013) |
| Phospholipids | Metabolites | SAX-RPLC-MS (N,P) | Bang et al. (2013) |
| Grape Seed | Food | HILIC×RPLC-MS (N,P) | Kalili et al. (2013) |
| Pharmaceuticals (enantiomeric excess) | Pharmaceuticals | NPLC-Chiral-UV-vis (N,P) | Liu et al. (2013) |
| Tryptic digest (BSA, lysozyme and myoglobine) | Peptides | RPLC×RPLC-UV-vis (N,P) | D'Attoma et al. (2013) |
| Lipidomics (porcine brain) | Metabolites | HILIC-RPLC-MS (F,M) | Cífková et al. (2013) |
| Synthetic polymers (cellulose acetates) | Polymers | NPLC-SEC-ELSD (F,M) | Ghareeb et al. (2013) |
| Tartary buckwheat | Natural medicines | RPLC-RPLC-UV-vis (N,P) | Ren et al. (2013) |
| Synthetic polymers (high-density polyethylene) | Polymers | RPLC×SEC-ELSD (N,P) | Ginzburg et al. (2013) |
| TCM (Hedyotis diffusa) | Natural medicines | RPLC×RPLC-MS, UV-vis (N,P) | Li et al. (2013) |
| Lipidomics (human plasma) | Metabolites | NPLC-RPLC-MS (N,V) | Li et al. (2013) |
| Pesticide residues | Food | HILIC-RPLC-MS (N,S) | Kittlaus et al. (2013) |
| Synthetic polymers (RAFT polymerization) | Polymers | LCCC×SEC-ELSD (N,P) | Keddie et al. (2013) |
| TCM (Amide alkaloids in Piper longumL.) | Natural medicines | NPLC×RPLC-MS (F,P) | Li et al. (2013) |
| Cocoa (procyanidins) | Food | HILIC×RPLC-FLD, UV-vis (N,P) | 10.1016/j.chroma.2013.03.009 (2013) |
| Synthetic polymers (polypropylene copolymers) | Polymers | NA-RPLC×SEC-ELSD (N,P) | Cheruthazhekatt et al. (2013) |
| Synthetic polymers (functionalized polyolefins) | Polymers | NA-RPLC×SEC-ELSD (N,P) | Ginzburg et al. (2013) |
| Pesticides | Food | HILIC-RPLC-MS (N,S) | Kittlaus et al. (2013) |
| Phospholipids | Metabolites | HILIC×RPLC-MS (N,O) | Dugo et al. (2013) |
| Apiaceous vegetables (furanocoumarins) | Food | RPLC-RPLC-UV-vis (N,P) | Larson et al. (2013) |
| Tryptic digest (porcine circovirus type 2) | Peptides | SCX-RPLC-MS (F,M) | Liu et al. (2013) |
| Peanut oil (triacylglycerols) | Food | NA-RPLC×AgLC-MS (F,M) | Hu et al. (2013) |
| Tryptic digest (antiviral factors) | Peptides | SCX-RPLC-MS (F,M) | Tong et al. (2013) |
| Pharmaceutical drugs | Pharmaceuticals | RPLC-Chiral-UV-vis (N,P) | Lee et al. (2013) |
| Fatty alcohol derivatives | Surfactants | HILIC×RPLC-MS (N,P) | Elsner et al. (2012) |
| Phenolic compounds | Metabolites | HILIC×RPLC-UV-vis (N,P) | Jandera et al. (2012) |
| Synthetic polymers (protonated and deuterated polystyrene) | Polymers | LCCC×SEC-ELSD (N,P) | Sinha et al. (2012) |
| Tryptic digest (Gly m 4 Protein) | Peptides | SAX-RPLC-MS, UV-vis (N,S) | Julka et al. (2012) |
| Pharmaceutical drugs | Pharmaceuticals | RPLC×HILIC-CAD, MS (F,M) | Schiesel (2012) |
| Synthetic polymers (poly(ethylene oxide)) | Polymers | RPLC×SEC-NMR (N,P) | Hiller et al. (2012) |
| Histone post-translational modifications | (Intact) Proteins | MM-RPLC-MS (F,M) | Tian et al. (2012) |
| Tryptic digest (scorpion Buthus martensi Karsch venom) | Peptides | RPLC-HILIC-MS (F,M) | Xu et al. (2012) |
| Synthetic polymers (Poly(styrene‚Äëb‚Äëisoprene) Miktoarm StarCopolymers) | Polymers | RPLC×SEC-ELSD, UV-vis (N,M) | Ljubič et al. (2012) |
| Synthetic polymers (PMMA and polyurethanes) | Polymers | RPLC×SEC-ELSD, UV-vis (N,P) | Uliyanchenko et al. (2012) |
| Tryptic digest (host cell protein impurities) | Peptides | RPLC-RPLC-MS (F,M) | Schenauer et al. (2012) |
| Synthetic oligonucleotides | Pharmaceuticals | HILIC×RPLC-MS (N,P) | Li et al. (2012) |
| Maize seeds | Food | RPLC×RPLC-UV-vis (N,P) | Allen et al. (2012) |
| TCM (Anemarrhena asphodeloides, steroid glycoside) | Natural medicines | RPLC×RPLC-MS (N,P) | Liu et al. (2012) |
| Tryptic digest (Methylocellasilvestris) | Peptides | RPLC-RPLC-MS (N,P) | Patel et al. (2012) |
| TCM (Qingkailing) | Natural medicines | RPLC-RPLC-MS, UV-vis (N,P) | Ma et al. (2012) |
| Natural organic matter | Environmental | HILIC×SEC-ELSD, FLD, UV-vis (N,P) | Duarte et al. (2012) |
| Natural organic matter | Environmental | RPLC×SEC-ELSD, FLD, UV-vis (N,P) | Duarte et al. (2012) |
| Tryptic digest (Bacillus thuringiensis) | Peptides | SCX-RPLC-MS (N,S) | Huang et al. (2012) |
| Natural antioxidants | Metabolites | RPLC-MEKC-UV-vis (F,M) | Česla et al. (2012) |
| TCM (Radix Angelica sinensis) | Natural medicines | RPLC×RPLC-MS (N,P) | Dück et al. (2012) |
| D‚Äê/L‚Äêphenylalanine | Pharmaceuticals | RPLC-Chiral-UV-vis (N,P) | Venkatramani et al. (2012) |
| D‚Äê/L‚Äêphenylalanine | Pharmaceuticals | RPLC×Chiral-UV-vis (N,P) | Venkatramani et al. (2012) |
| Organic acids (aromatics and flavanoids) | Metabolites | RPLC×RPLC-UV-vis (N,P) | Hájek et al. (2012) |
| Shotgun proteomics | Peptides | HILIC-RPLC-MS (N,S) | Zhao et al. (2012) |
| Rooibos tea (phenolics) | Food | HILIC×RPLC-UV-vis (N,P) | Beelders et al. (2012) |
| TCM (Stevia Rebaudiana) | Natural medicines | RPLC×HILIC-MS (F,M) | Fu et al. (2012) |
| Synthetic polymers (polystyrene-polyethylene oxide block copolymers) | Polymers | LCCC×SEC-ELSD (N,P) | Malik et al. (2012) |
| TCM (Panax notoginseng saponins) | Natural medicines | HILIC×RPLC-MS, UV-vis (F,M) | Xing et al. (2012) |
| Peanut oil and mouse tissue (triacylglycerides) | Lipids | AgLC-RPLC-MS (N,P) | Yang et al. (2012) |
| Synthetic polymers (Branched Polymers) | Polymers | RP-TGIC×SEC-LS, RI, VI (N,P) | Ahn et al. (2012) |
| Synthetic polymers (Poly(styrene-block-t-butyl methacrylate) Copolymers) | Polymers | RPLC×SEC-ELSD (N,P) | Ljubič et al. (2012) |
| Synthetic polymers (Poly(styrene-block-t-butyl methacrylate) Copolymers) | Polymers | LCCC×SEC-ELSD (N,P) | Ljubič et al. (2012) |
| Tryptic digest (neutrophils) | Peptides | SCX-RPLC-MS (F,M) | Trusch et al. (2012) |
| Synthetic polymers (PDMS-PS block copolymers) | Polymers | LCCC×SEC-ELSD, UV-vis (F,P) | Malik et al. (2012) |
| Endocrine disrupting compounds in water | Environmental | RPLC-RPLC-MS (N,P) | David Matějíček (2012) |
| Corn seed | Metabolites | RPLC×RPLC-UV-vis (N,P) | Paek et al. (2012) |
| Tryptic digest (rat brain) | Peptides | RPLC-WCX-MS (F,M) | Cai et al. (2012) |
| Maize seed extract | Food | RPLC×RPLC-UV-vis (N,P) | Zhang et al. (2012) |
| Wastewater effluent (cocaince) | Environmental | RPLC-RPLC-MS (N,P) | Groskreutz et al. (2012) |
| Opiates | Pharmaceuticals | RPLC-RPLC-UV-vis (N,P) | Groskreutz et al. (2012) |
| Taxanes | Pharmaceuticals | HILIC-RPLC-MS (N,P) | Rezadoost et al. (2012) |
| Licorice (liquiritin) | Food | RPLC×RPLC-UV-vis (F,P) | Cong et al. (2012) |
| Synthetic polymers (polypropylene Copolymers) | Polymers | RPLC×SEC-ELSD (N,P) | Cheruthazhekatt et al. (2012) |
| Organic acids | Metabolites | RPLC×RPLC-UV-vis (N,P) | Duarte et al. (2012) |
| TCM (Scutellaria barbata D. Don) | Natural medicines | HILIC×RPLC-MS, UV-vis (F,M) | Liang et al. (2012) |
| TCM (Scutellaria barbata D. Don) | Natural medicines | HILIC×HILIC-MS, UV-vis (F,P) | Liang et al. (2012) |
| Tryptic digest (phosphorylated peptides) | Peptides | RPLC-RPLC-MS (F,M) | Stephanowitz et al. (2012) |
| Green and black tea (Camellia sinensis, phenolics) | Food | SEC×RPLC-ELSD, UV-vis (F,M) | Scoparo et al. (2012) |
| Tryptic digest (serum) | Peptides | SCX-RPLC-MS (F,M) | Zhang et al. (2012) |
| TCM (flavanoids) | Natural medicines | RPLC-RPLC-MS (F,M) | Zeng et al. (2012) |
| Monoclonal antibodies | Biopharma | RPLC-RPLC-MS (N,S) | Doneanu (2012) |
| Alkylphenol polyethoxylates | Surfactants | HILIC×RPLC-MS (N,P) | Wu et al. (2011) |
| Monoclonal antibodies | Biopharma | MM-RPLC-MS, UV-vis (N,S) | Alvarez et al. (2011) |
| Maize extract | Food | RPLC×RPLC-UV-vis (N,P) | Filgueira et al. (2011) |
| Synthetic polymers (poly(2-ethyl-2-oxazoline) copolymers) | Polymers | LCCC×SEC- (N,P) | Baumgaertel et al. (2011) |
| TCM | Natural medicines | RPLC-HILIC-UV-vis (F,S) | Cao et al. (2011) |
| Synthetic polymers (poly(ethylene-co-propylene)) | Polymers | RPLC×SEC-IR, LS, RI (N,P) | Lee et al. (2011) |
| Synthetic polymers (polystyrene) | Polymers | SEC×HDC-UV-vis (F,M) | Uliyanchenko et al. (2011) |
| Maize extract | Food | RPLC×RPLC-UV-vis (N,P) | Gu et al. (2011) |
| Hydroxypropylmethylcellulose (HPMC) | Polymers | RPLC×SEC-CAD (N,P) | Greuderer et al. (2011) |
| Lipidomics (egg, soya, porcine brain) | Metabolites | HILIC-NA-RPLC-MS (F,M) | Lísa et al. (2011) |
| Myoglobin, serum albumin, pepstatin, proteinase inhibitor | (Intact) Proteins | SCX-RPLC-MS, UV-vis (N,S) | Julka et al. (2011) |
| River water (pollutants in Monjolinho River) | Environmental | Affinity-Chiral-MS (N,P) | Barreiro et al. (2011) |
| Tryptic digest (Trypsin, bovine serum, ovalbumin, lysozyme, hemoglobin) | Peptides | WAX-RPLC-UV-vis (N,P) | Li et al. (2011) |
| Estrogens in sediments | Environmental | RPLC-RPLC-MS (N,P) | David Matějíček (2011) |
| Synthetic polymers (polyolefins) | Polymers | RPLC×SEC-ELSD (N,P) | Ginzburg et al. (2011) |
| Borago officinalis oil (triacylglycerols) | Lipids | AgLC×NA-RPLC-ELSD (N,P) | Mondello et al. (2011) |
| Flavones in Citrus juices | Food | RPLC×RPLC-UV-vis (N,P) | Russo et al. (2011) |
| Peptides | Peptides | RPLC-CE-MS (N,P) | Chambers et al. (2011) |
| Metabolites (Saccharomyces cerevisae) | Metabolites | SCX×HILIC-MS (F,M) | Fairchild et al. (2010) |
| Non-ionic surfactants (Polysorbates, Tween) | Surfactants | LCCC×HILIC-ELSD (N,P) | Abrar et al. (2010) |
| Block copolymers | Polymers | LCD-SEC-ELSD (N,P) | Berek et al. (2010) |
| Phospholipids (plasma) | Lipids | WAX-RPLC-MS (N,M) | Sato et al. (2010) |
| Synthetic polymers (2-ethylhexyl acrylate and methyl acrylate RAFT) | Polymers | SEC×LCCC-ELSD (N,P) | Raust et al. (2010) |
| Antibody-drug conjugates | Biopharmaceuticals | Affinity-RPLC-MS (N,P) | Murphy et al. (2010) |
| Synthetic polymers (thylene-vinylacetate copolymers) | Polymers | NPLC×SEC-ELSD (N,P) | Ginzburg et al. (2010) |
| Low-molar-mass organic acids | Food | SAX×RPLC-UV-vis (N,P) | Brudin et al. (2010) |
| espresso coffees (ristretto, decaffeinatto, volluto) | Food | RPLC×RPLC-Other, UV-vis (N,P) | Mnatsakanyan et al. (2010) |
| Lipidomics (rat serum) | Metabolites | NPLC-RPLC-MS (N,V) | Nie et al. (2010) |
| Anti-PEG Antibody digest | Peptides | SCX-RPLC-MS (N,P) | Xu et al. (2010) |
| Coal tar | Miscellaneous | NPLC-RPLC-UV-vis (N,V) | Ding et al. (2010) |
| arctiin in fruit (Arctium lappa L.) | Food | CCC-RPLC-UV-vis (N,P) | Guo et al. (2010) |
| omeprazole in waste and estuarine water | Environmental | Affinity-Chiral-MS (N,P) | Barreiro et al. (2010) |
| TCM (Herba Hedyotis Diffusae) | Natural medicines | RPLC×HILIC-UV-vis (F,M) | Feng et al. (2010) |
| TCM (platycosides in Platycodi Radix) | Natural medicines | RPLC×RPLC-MS (N,P) | Jeong et al. (2010) |
| Antibody tryptic digests | Peptides | Affinity-RPLC-MS, UV-vis (N,P) | Cho et al. (2010) |
| Phenolic acids and flavones | Food | RPLC×RPLC-UV-vis (N,P) | Jandera et al. (2010) |
| Tryptic digest (pertussis toxoid) | Peptides | RPLC-RPLC-MS (F,M) | Tummala et al. (2010) |
| Synthetic polymers (fatty alcohol ethoxylates) | Polymers | RPLC×NPLC-ELSD (N,P) | Raust et al. (2010) |
| Chiral enantiomers (amino acids in irradiated foodstuffs) | Food | RPLC-Chiral- (N,P) | Guillén-Casla et al. (2010) |
| Human plasma protein | Peptides | SCX-RPLC-MS (F,M) | Ahrends et al. (2010) |
| TCM (Corydalis yanhusuo, antinociceptive components) | Natural medicines | RPLC×RPLC-MS, UV-vis (N,P) | Wang et al. (2010) |
| Drug metabolites in urine | Metabolites | RPLC-RPLC-MS (N,S) | Jayamanne et al. (2010) |
| Synthetic polymers (polyoxyalkylene block copolymers) | Polymers | LCCC-SEC-MS (F,M) | Malik et al. (2010) |
| Synthetic polymers (Polysorbates) | Polymers | NPLC×LCCC-ELSD (N,P) | Trathnigg et al. (2010) |
| Cr-enriched yeast | Miscellaneous | SEC-RPLC-MS (F,M) | Kaewkhomdee et al. (2010) |
| TCM (Rheum Palmatum L) | Natural medicines | RPLC×RPLC-UV-vis (F,M) | Xue et al. (2009) |
| Whey protein hydrolysate | Peptides | RPLC×RPLC-UV-vis (N,P) | Bedani et al. (2009) |
| Polyphenols in red wines | Food | RPLC×RPLC-MS, UV-vis (N,P) | Mondello et al. (2009) |
| Polyphenolic antioxidants in red wine | Food | RPLC×RPLC-MS, UV-vis (N,P) | Dugo et al. (2008) |
| Tryptic digest (transferrin, BSA, alcohol dehydrogenase, lysozyme, cytochrome c, beta-casein, mAb) | Peptides | SCX×RPLC-MS, UV-vis (N,P) | Eeltink et al. (2009) |
| TCM (Zhengtian pills) | Natural medicines | NPLC×RPLC-UV-vis (N,O) | Wei et al. (2009) |
| Polyphenols in mate extracts | Food | RPLC×RPLC-MS, UV-vis (N,P) | Dugo et al. (2009) |
| Tryptic digest (Human Glioblastoma Multiforme Tissue) | Peptides | SCX-IP-RPLC-MS (F,M) | Melchior (2009) |
| Recombinant antibody-related drugs (rAbs) | Peptides | Affinity-RPLC-UV-vis (N,P) | Zhang et al. (2009) |
| Synthetic polymers (Caprolactone) | Polymers | LCCC×RPLC-ELSD (F,M) | Ahmed et al. (2009) |
| Taxanes in Taxus baccata L. | Natural medicines | RPLC-RPLC-UV-vis (N,P) | Ghassempour et al. (2009) |
| Epoxy resins | Polymers | SEC×LCCC-MS, UV-vis (N,P) | Julka et al. (2009) |
| Complex polymers (PS-b-PI-b-PS triblock copolymer, mikto arm block copolymer) | Polymers | SEC×NPLC-UV-vis (N,P) | Im et al. (2009) |
| Complex polymers (PS-b-PI-b-PS triblock copolymer, mikto arm block copolymer) | Polymers | RP-TGIC×SEC-UV-vis (N,P) | Im et al. (2009) |
| Cytochrome c, myoglobin, ribonuclease A, lysozyme, alpha-amylase, alpha-chymotrypsin, insulin | (Intact) Proteins | HIC-WCX-MS (N,P) | Geng et al. (2009) |
| Antioxidants | Metabolites | RPLC×RPLC-UV-vis (N,P) | Česla et al. (2009) |
| Active pharmaceutical ingredients (API) and degradants | Pharmaceuticals | RPLC×RPLC-UV-vis (N,P) | Alexander et al. (2009) |
| TCM (Fructus aurantii, flavones) | Natural medicines | RPLC-RPLC-MS, UV-vis (F,M) | Zhou et al. (2009) |
| Tryptic digest (BSA, cytochrome c, beta-casein, myoglobin and lysozyme) | Peptides | SCX-RPLC-MS (F,M) | Wang et al. (2009) |
| Flavonol glycosides from leaves of Maytenus ilicifolia | Natural medicines | SEC×RPLC-MS (F,M) | de Souza et al. (2009) |
| TCM (Carthamus tinctorius Linn.) | Natural medicines | RPLC-HILIC-UV-vis (F,M) | Liu et al. (2008) |
| Manganese binding to biomolecules in pine nuts | Food | SEC-RPLC- (F,M) | Arias-Borrego et al. (2008) |
| Synthetic polymers (Polystyrene‚Äêblock‚ÄêPolyisoprene Diblock Copolymers) | Polymers | LCCC×SEC-ELSD (N,P) | Mass et al. (2008) |
| Synthetic polymers ((meth)acrylate-based copolymers) | Polymers | NA-RPLC×SEC-ELSD (N,P) | Raust et al. (2008) |
| Sulphonated lignins | Polymers | IP-RPLC×SEC- (N,P) | Brudin et al. (2008) |
| Phenolic compounds in beverages | Food | RPLC×RPLC- (N,P) | Kivilompolo et al. (2008) |
| Synthetic polymers (branched polymers) | Polymers | MTF×SEC-UV-vis (N,P) | Edam et al. (2008) |
| Protein extracts | (Intact) Protein | IEF-RPLC-UV-vis (F,M) | Suberbielle et al. (2008) |
| 2-acetyl-4-(1,2,3,4-tetrahydroxybutyl)imidazole in Class III caramel colours | Food | RPLC-RPLC-UV-vis (N,P) | Moretton et al. (2008) |
| TCM (Lobelia chinensis Lour.) | Natural medicines | RPLC-RPLC-MS, UV-vis (F,M) | Zhou et al. (2008) |
| TCM (Radix salviae miltiorrhiza bage) | Natural medicines | NPLC×RPLC-MS (N,V) | Tian et al. (2008) |
| Carotenoids in Red Orange Oil | Food | NPLC×RPLC-MS, UV-vis (N,P) | Dugo et al. (2008) |
| Alprazolam | Pharmaceuticals | RPLC×RPLC-UV-vis (F,M) | Huidobro et al. (2008) |
| Tryptic digest (cytochrome C, lysozyme C, alcohol dehydrogenase, BSA, serotransferrin) | Peptides | SCX-RPLC- (N,S) | Hesse et al. (2008) |
| Phenolic acids | Metabolites | RPLC×RPLC-UV-vis (N,P) | Jandera et al. (2008) |
| Antioxidant phenols in wine and juice | Food | RPLC×RPLC-UV-vis (N,P) | Kivilompolo et al. (2008) |
| Peptides in milk hydrolysates | Food | RPLC-HILIC-MS (F,M) | Platerink et al. (2008) |
| Pharmaceuticals in urine | Pharmaceuticals | RPLC×RPLC-MS, UV-vis (N,P) | Eggink et al. (2008) |
| Tryptic digest (myoglobin and BSA) | Peptides | SCX×RPLC-UV-vis (F,M) | Marchetti et al. (2008) |
| TCM (Swertia franchetiana Smith) | Natural medicines | RPLC-RPLC-MS (F,M) | Liu et al. (2008) |
| Polyphenols | Metabolites | RPLC×RPLC-UV-vis (N,P) | Jandera et al. (2008) |
| TCM (saponins from Quillaja saponaria) | Natural medicines | HILIC×HILIC-MS (N,P) | Wang et al. (2008) |
| Lemon oil extract | Food | NPLC×RPLC- (N,P) | Fran√ßois et al. (2008) |
| Triacylglycerols in corn oil | Food | AgLC×RPLC-ELSD, MS, UV-vis (N,P) | van der Klift et al. (2008) |
| Active components in licorice | Food | RPLC-RPLC-UV-vis (N,P) | Cong et al. (2008) |
| Taxus baccata L. | Natural medicines | RPLC-RPLC-UV-vis (N,P) | Ghassempour et al. (2008) |
| Corn seed powder extract | Metabolites | RPLC×RPLC-UV-vis (N,P) | Stoll et al. (2008) |
| TCM (Magnolia biondii, lignans) | Natural medicines | RPLC-RPLC-UV-vis (N,P) | Zhao et al. (2007) |
| High intensity sweeteners in plants | Food | RPLC×RPLC-MS (N,P) | P√≥l et al. (2007) |
| High intensity sweeteners in plants | Food | SCX×RPLC-MS (N,P) | P√≥l et al. (2007) |
| Polyphenols in beverages | Food | RPLC×RPLC-UV-vis (N,S) | Cacciola et al. (2007) |
| Tryptic digest (HepG2 proteome) | Peptides | SCX-RPLC-MS (N,P) | Yamashita et al. (2007) |
| TCM (Flos Lonicera) | Natural medicines | SAX×RPLC-MS, UV-vis (N,P) | Chen et al. (2007) |
| Tryptic digest (cytochrome c) | Peptides | SCX-RPLC-MS (N,P) | Liu et al. (2007) |
| Apo A‚ÄêI in human plasma | (Intact) Proteins | RPLC-SAX-UV-vis (N,S) | Pepaj et al. (2007) |
| Antioxidant phenolic acids in Lamiaceae herbs | Food | RPLC×RPLC-MS (N,P) | Kivilompolo et al. (2007) |
| excreta (feces or urine) extracts from rats or mice | Metabolites | RPLC-RPLC-MS, UV-vis (F,M) | Kiffe et al. (2007) |
| Tryptic digest (cell lysate) | Peptides | HILIC-RPLC- (F,M) | Boersema et al. (2007) |
| Metabolites in urine | Metabolites | RPLC-RPLC-MS (F,M) | Trunzer et al. (2007) |
| Synthetic polymers (PS-b-PI diblock copolymer) | Polymers | NP-TGIC×NA-RPLC-UV-vis (N,S) | Im et al. (2007) |
| TCM (Angelica dahurica) | Natural medicines | NPLC-RPLC-UV-vis (N,V) | Tian et al. (2006) |
| BioZate3 | Peptides | SEC×RPLC-MS, UV-vis (N,O) | Bedani et al. (2006) |
| Phenolic antioxidants | Food | RPLC×RPLC-UV-vis (N,S) | Cacciola et al. (2006) |
| Tryptic digest (proteins extracted from normal human liver tissue) | Peptides | SCX-RPLC-MS (N,P) | Gu et al. (2006) |
| Acidic compounds in atmospheric aerosols | Environmental | SCX×RPLC-MS (N,P) | P√≥l et al. (2006) |
| Synthetic polymers (poly(ethylene glycol)-poly(vinyl acetate) graft copolymers) | Polymers | LCCC×SEC-ELSD (N,P) | Knecht et al. (2006) |
| Poly(bisphenol A)carbonate and polymers | Polymers | LCCC×SEC-IR (N,P) | Coulier et al. (2006) |
| Synthetic polymers (Linear and 3‚ÄêArm Star Block Copolymers) | Polymers | LCCC×SEC-ELSD (N,P) | Gao et al. (2006) |
| TCM (Adinandra nitida) | Natural medicines | RPLC×RPLC-MS, UV-vis (N,P) | Zhang et al. (2006) |
| TCM (Qingkailing) | Natural medicines | SEC×RPLC-UV-vis (F,M) | Ma et al. (2006) |
| Biomarkers in rat plasma | Peptides | IEF-RPLC-MS (F,P) | Linke et al. (2006) |
| Indoles in wild-type maize seed extracts | Metabolomics | SCX×RPLC-UV-vis (N,P) | Porter et al. (2006) |
| Tryptic digest (bovine serum albumin, BSA) | Peptides | SCX×RPLC-UV-vis (N,P) | Stoll et al. (2005) |
| Synthetic polymers (thylene oxide‚Äìpropylene oxide (co)oligomers) | Polymers | RPLC×HILIC-ELSD (N,P) | Jandera et al. (2006) |
| Selenium species in aqueous extracts of alfalfa sprouts | Metabolites | SEC×IP-RPLC-ICP-MS (F,P) | Gergely et al. (2006) |
| Triacylglycerols | Lipids | AgLC×NA-RPLC-MS (N,P) | Dugo et al. (2006) |
| Triacylglycerols in milk | Food | AgLC×NA-RPLC-MS (N,P) | Dugo et al. (2006) |
| Tryptic digest (plant tissues) | Peptides | HPCF×RPLC-MS (N,P) | Pirondini et al. (2006) |
| Synthetic polymers (poly(bisphenol A)carbonate, degraded) | Polymers | LCCC×SEC-IR, MS (N,P) | Coulier et al. (2006) |
| Polyphenols | Food | NPLC×RPLC-UV-vis (N,P) | Dugo et al. (2006) |
| Synthetic polymers (styrene-methylacrylate (SMA) copolymers) | Polymers | RPLC×SEC-IR, UV-vis (N,P) | Kok et al. (2005) |
| Triacylglycerol in food | Lipids | AgLC×NA-RPLC-MS, UV-vis (N,P) | Mondello et al. (2005) |
| Tryptic digest (C. elegans) | Peptides | SCX-RPLC-MS (N,S) | Tschäppät et al. (2005) |
| Synthetic polymers (poly(bisphenol A)carbonate) | Polymers | NPLC×SEC-UV-vis (N,P) | Coulier et al. (2005) |
| Synthetic polymers (poly(bisphenol A)carbonate) | Polymers | LCCC×SEC-UV-vis (N,P) | Coulier et al. (2005) |
| Organic acids | Metabolites | RPLC×MM-UV-vis (N,P) | Venkatramani et al. (2005) |
| Tryptic digest (D20) | Peptides | RPLC-SCX-MS (N,S) | Wang et al. (2005) |
| Synthetic polymers (poly(methyl methacrylate)) | Polymers | LCCC×SEC-ELSD, UV-vis (N,P) | Jiang et al. (2005) |
| Synthetic polymers (n-butyloligostyrenes) | Polymers | RPLC-RPLC-UV-vis (N,P) | Gray et al. (2005) |
| Tryptic digest (26S and 20S proteasome) | Peptides | SCX-RPLC-MS (F,M) | Fujii et al. (2004) |
| Tryptic digest (PUMA-Induced Apoptosis samples) | Peptides | SCX-RPLC-MS (N,P) | Gu et al. (2004) |
| Tryptic digest (saliva proteome) | Peptides | SCX-RPLC-MS (F,M) | Wilmarth et al. (2004) |
| Tryptic digest (human serum proteins) | Peptides | RPLC-CE-MS (F,M) | Janini et al. (2004) |
| TCM (Rhizoma chuanxiong) | Natural medicines | RPLC×RPLC-MS, UV-vis (N,P) | Chen et al. (2004) |
| Oligoalanine peptide stereoisomers | Peptides | RPLC-Chiral-MS (N,P) | Czerwenka et al. (2004) |
| Clerodendrum floribundum | Natural medicines | RPLC-RPLC-UV-vis (N,P) | Wong et al. (2004) |
| Synthetic polymers (PLA/PDMS graft terpolymers) | Polymers | LCCC×SEC-ELSD (N,P) | Lutz et al. (2004) |
| Tryptic digests (A431) | Peptides | SCX-RPLC-MS (N,P) | Chelius et al. (2003) |
| Synthetic polymers (poly(methyl methacrylate)) | Polymers | RPLC×SEC-ELSD (N,P) | Siewing et al. (2003) |
| Tryptic digest (bovine proteins) | Peptides | SCX-RPLC-MS (N,P) | Nägele et al. (2003) |
| Aromatic and non-aromatic amines | Metabolites | RPLC×RPLC-UV-vis (N,P) | Venkatramani et al. (2003) |
| Synthetic polyemers (polystyrene, PMMA) | Polymers | NA-RPLC×SEC-UV-vis (N,P) | van der Horst et al. (2003) |
| Triacylglycerides in edible oils and fats | Lipids | AgLC×GC-FID (F,M) | Janssen et al. (2003) |
| Triacylglycerides in edible oils and fats | Lipids | NPLC×GC-FID (F,M) | Janssen et al. (2003) |
| Tryptic digest (Caenorhabditis elegans) | Peptides | SCX-RPLC-MS (N,S) | Mawuenyega et al. (2003) |
| Synthetic polymers (styrene-butadiene and butyl rubber) | Polymers | NA-RPLC×SEC-ELSD (N,P) | Heinz et al. (2003) |
| Tryptic digest (protein mixtures) | Peptides | SCX-RPLC-MS (N,S) | Qiu et al. (2002) |
| Selenium-containing biomolecules from yeast extracts | Peptides | SEC-RPLC-ICP-MS (F,M) | Lindemann et al. (2002) |
| Synthetic polymers (polystyrene) | Polymers | RPLC-RPLC-UV-vis (N,S) | Sweeney and Shalliker (2002) |
| Fatty acid polyglycol ethers | Surfactants | LCCC-RPLC-ELSD, RI (N,S) | Trathnigg et al. (2002) |
| Cell extracts (proteins, metabolites) | (Intact) Proteins | RPLC×CE-UV-vis (F,M) | He et al. (2002) |
| Biological matrices (incl pecan nut, straw, mouse plasma) | Miscellaneous | RPLC-RPLC-MS (N,P) | Pascoe et al. (2001) |
| Synthetic polymers (EPDM polymers with grafted methyl methacrylate) | Polymers | LCCC×NA-RPLC-ELSD, UV-vis (N,P) | Siewing et al. (2001) |
| Proteins from human breast cancer whole cell lysates | (Intact) Proteins | HPCF-RPLC-MS (F,M) | Chong et al. (2001) |
| Selenium speciation in selenized yeast extracts | (Intact) Proteins | SEC-RPLC-ICP-MS (F,M) | McSheehy et al. (2001) |
| Proteins (mixture) | (Intact) Proteins | SCX×RPLC-MS, UV-vis (N,P) | Wagner et al. (2000) |
| JP-TS jet fuel | Energy carriers | GC×GC-FID (N,O) | Fraga et al. (2000) |
| t,t-muconic acid in human urine | Metabolites | RPLC-RPLC-UV-vis (N,S) | Serena et al. (2000) |
| Fatty alcohol ethoxylates | Polymers | LCC-SEC-ELSD (N,P) | Trathnigg et al. (1999) |
| Alcohol Ethoxylates | Surfactants | NPLC×RPLC-ELSD (N,P) | Murphy et al. (1998) |
| Tryptic digest (BSA) | Peptides | SEC-RPLC-MS (N,P) | Opiteck et al. (1998) |
| Tryptic digests (ovalbumin and serum albumin) | Peptides | SEC×RPLC-MS (N,P) | Opiteck et al. (1997) |
| Escherichia coli cell lysate | Proteins | SCX×RPLC-MS, UV-vis (N,P) | Opiteck et al. (1997) |
| fluorescein 5-isothiocyanate (FITC)-labeled phenylalanine and glutamic acid | Metabolites | RPLC-CE-LIF (N,O) | Hooker et al. (1997) |
| Polyesters, polyethers and macromers | Polymers | LCCC-SEC-MS (F,M) | Krüger et al. (1996) |
| Ethoxylated fatty alcohols | Surfactants | LCCC×SEC-RI (F,M) | Trathnigg et al. (1995) |
| Biological amines | Metabolites | SAX-RPLC-UV-vis (N,P) | Holland et al. (1995) |
| Ethoxylated fatty alcohols | Surfactants | LCCC×SEC-RI (F,M) | Trathnigg et al. (1994) |
| Peptide from rat brain tissue | Peptides | SAX-RPLC-UV-vis (F,M) | Lundell et al. (1992) |
| Additives in cellulose acetate polymer | Miscellaneous | SEC-RPLC-UV-vis (N,P) | Th. R. Floyd (1988) |
| Plant extracts | Metabolites | SEC-RPLC-UV-vis (N,P) | Erni and Frei (1978) |
| Protein mixtures | (Intact) Proteins | SCX×SEC-UV-vis (N,P) | Bushey and Jorgenson (1990) |
| Monoclonal antibodies | Biopharma | SEC×SEC-MS (N,P) | Ehkirch et al. (2018) |
| TCM (Flos Lonicerae Japonicae) | Natural medicines | HILIC×RPLC-MS, UV-vis (F,M) | Zhao et al. (2019) |
| Josamycin (degradation products and impurities) | Pharmaceuticals | RPLC-RPLC-MS (N,P) | Liu et al. (2019) |
| Enoxaparins | Pharmaceuticals | SEC-RPLC-MS (N,P) | Ouyang et al. (2019) |
| Acrylate-modified hyaluronic acid | Polymers | RPLC×SEC-ELSD (N,P) | Viktor et al. (2019) |
| Poly-1-octene (tacticity) | Polymers | RPLC×SEC-ELSD, RI, NMR (N,P) | Rode et al. (2019) |
| Metal-based anticancer drugs | Pharmaceuticals | SEC-RPLC-ICP-MS (N,P) | Galvez et al. (2019) |
| TCM (Arenaria kansuensis) | Natural medicines | RPLC-RPLC-UV-vis (F,P) | Cui et al. (2019) |
| Gluconic acid in honey samples | Food | SEC-RPLC-MS (N,P) | Suto et al. (2019) |
| tartary buckwheat (Fagopyrum tataricum) seeds | Peptides | RPLC-RPLC-MS (F,M) | Wang et al. (2019) |
| Lignocellulosic biomass products | Miscellaneous | CPC×RPLC-MS (F,M) | Dubuis et al. (2019) |
| Polyphenolic fraction of Pistacia vera L. kernel extracts | Food | RPLC×RPLC-MS (N,P) | Arena et al. (2019) |
| Monoterpene indole alkaloids in biological matrices | Food | SCX-RPLC-MS (N,P) | Liu et al. (2019) |
| Branching analysis of star-shaped polystyrenes | Polymers | TGIC×SEC-LS, RI, VI (N,P) | Murima et al. (2019) |
| Pesticide multi-screening | Environmental | HILIC-RPLC-MS (N,P) | Muehlwald et al. (2019) |
| Drug metabolites | Pharmaceuticals | RPLC-RPLC-MS, UV-vis (N,S) | Koppen et al. (2019) |
| Pesticides | Environmental | RPLC-RPLC-UV-vis (N,P) | Pursch et al. (2017) |
| Cytochrome C, carbonic anhydrase, beta-casein, beta-lactoglobulin, alpha-lactalbumin | Proteins | RPLC×RPLC-MS (N,P) | Baghdady et al. (2019) |
| Asn, Ser, Ala and Pro Enantiomers | Pharmaceuticals | RPLC-WAX-FLD (N,P) | Furusho et al. (2019) |
| Leucomycin (charactrization and impurity profiling) | Pharmaceuticals | RPLC-RPLC-MS, UV-vis (N,P) | Wang et al. (2019) |
| Synthetic polymers (vinyl acetate/acrylic acid copolymers and vinyl acetate/itaconic acid/acrylic acid terpolymers) | Polymers | SEC×RPLC-ELSD (N,A) | Yang et al. (2019) |
| Aqueous-phase extracts of pyrolyzed bio-oils of different biomasses | Miscellaneous | RPLC×RPLC-MS, UV-vis (N,P) | Lazzari et al. (2019) |
| TCM (Flavonoid glycosides from Lobelia chinensis Lour) | Natural medicines | RPLC×HILIC-MS (F,M) | Wang et al. (2019) |
| Microalgae gastro-intestinal digests | Peptides | HILIC×RPLC-MS (N,S) | Sommella et al. (2019) |
| TCM (bufadienolides in Venenum Bufonis) | Natural medicines | RPLC×SFC-UV-vis (F,M) | Wei et al. (2019) |
| Polycyclic Aromatic Hydrocarbons in Water Samples | Environmental | Affinity-RPLC-FLD (N,P) | Armutcu et al. (2019) |
| TCM (ginsenosides in Panax notoginseng leaves) | Natural medicines | HILIC×RPLC-MS (N,S) | Cao et al. (2019) |
| Triazole fungicides in vegetables and fruits | Food | RPLC-Chiral-UV-vis (N,P) | Zeng et al. (2019) |
| Gangliosides profiling in swine brain extract | Lipids | SFC×RPLC-MS (F,P) | Si et al. (2019) |
| Therapeutic antibodies | Biopharma | RPLC×RPLC-MS (N,A) | Stoll et al. (2019) |
| Antisense Oligonucleotide Impurities | Biopharma | AEX-HILIC-MS (N,P) | Goyon et al. (2020) |
| Intact proteins | Intact Proteins | RPLC×RPLC-UV-vis (N,P) | Wang et al. (2020) |
| Phenolic fraction in extra virgin olive oils | Food | RPLC×RPLC-MS (N,P) | Arena et al. (2020) |
| Pesticides | Environmental | HILIC-RPLC-MS (N,S) | Jost et al. (2020) |
| Posaconazole related stereoisomers | Biopharma | Chiral-Chiral-UV (N,P) | Xu et al. (2020) |
| Cardiolipins and their oxidation products | Metabolites | HILIC-RPLC-MS (N,P) | Helmer et al. (2020) |
| Emerging mycotoxins in Pu-erh tea | Food | RPLC-RPLC-MS (N,P) | Bogdanova et al. (2020) |
| Complex pharmaceutical samples | Biopharma | RPLC-Chiral-UV-vis (N,P) | Lin et al. (2020) |
| Pesticide analysis | Environmental | HILIC-RPLC-MS (N,P) | Muehlwald et al. (2020) |
| Synthetic oligonucleotides | Biopharma | MM-RPLC-MS (N,P) | Li et al. (2020) |
| Synthetic and therapeutic peptides | Biopharma | RPLC-RPLC-MS (N,A) | Karongo et al. (2020) |
| Pharmaceutical compounds | Pharmaceuticals | RPLC×RPLC-UV-vis (N,P) | Aly et al. (2020) |
| Impurities in rutin tablets | Food | RPLC-RPLC-MS (N,P) | Wang et al. (2020) |
| Impurities in roxithromycin | Pharmaceuticals | RPLC-RPLC-MS (N,P) | Wang et al. (2020) |
| Mycotoxins in beer | Food | RPLC-RPLC-MS (N,P) | Campone et al. (2020) |
| Polyphenolic fingerprints for classification of olive leaves and pulp extracts | Food | RPLC×RPLC-UV-vis (N,P) | Vergara-Barberán et al. (2020) |
| Hydroxyl radical footprinting analysis | Peptides | RPLC-RPLC-MS (N,P) | Camperi et al. (2020) |
| free sterols/stanols and steryl/stanyl esters in walnut | Food | RPLC-GC-MS (N,P) | Apedo et al. (2019) |
| Impurities in mezlocillin sodium | Pharmaceuticals | RPLC-RPLC-MS (N,P) | Wang et al. (2019) |
| TCM (ginsenosides from white and red ginsengs) | Natural medicines | HILIC×RPLC-MS (N,S) | Zhang et al. (2019) |
| Posaconazole stereoisomers | Biopharma | Chiral-Chiral-UV-vis (N,P) | Xu et al. (2020) |
| Benzophenone degradants after water chlorination | Environmental | RPLC-BMC-UV-vis (N,P) | Li et al. (2020) |
| Screening of drug substances | Biopharma | RPLC×RPLC-MS (N,P) | Pickens et al. (2020) |
| Screening of drug substances | Biopharma | SEC×RPLC-MS (N,P) | Pickens et al. (2020) |
| Valproic acid in human serum | Pharmaceuticals | RPLC-RPLC-UV-vis (N,P) | Liu et al. (2020) |
| Folic acid in human plasma | Metabolites | RPLC-RPLC-MS (N,P) | Hyung et al. (2020) |
| identification of modified nucleosides from RNA metabolism | Metabolites | RPLC×RPLC-MS (N,P) | Willmann (2020) |
| Metabolites from white ginseng and red ginseng | Metabolites | HILIC-RPLC-MS (F,M) | Zuo et al. (2020) |
| Microalgae (astaxanthin in Haematococcus pluvialis) | Food | NPLC×RPLC-MS (N,P) | Gallego et al. (2020) |
| Risperidone and 9-Hydroxyrisperidone in Human Serum | Biopharma | SCX-RPLC-UV-vis (N,S) | Liu et al. (2020) |
| Extracted pesticides and polar pesticides | Environmental | HILIC-RPLC-MS (N,P) | Jost et al. (2020) |
| Pharmaceuticals with multiple chiral centers | Biopharma | RPLC-Chiral-UV-vis (N,P) | Lin et al. (2020) |
| Aromatic amine oligomer | Miscellaneous | RPLC×RPLC-MS (N,P) | Zhu et al. (2020) |
| Lignocellulosic biomass products | Miscellaneous | SEC×RPLC-MS (F,M) | Dubuis et al. (2020) |
| Polar compounds | Metabolites | ZWIX×HILIC-CAD (N,P) | Bäurer et al. (2020) |
| Lipidomics of human plasma | Lipids | NPLC-RPLC-MS (N,V) | Yang et al. (2020) |
| Impurities in dye-conjugated oligonucleotides | Biopharma | IP-RPLC-IP-RPLC-MS (N,P) | Koshel et al. (2020) |
| Aged plastic bonded explosives | Forensics | RPLC×SEC-UV-vis (N,P) | Freye et al. (2020) |
| Gangliosides in brain serum | Metabolites | SFC×RPLC-MS (F,M) | Si et al. (2020) |
| Proteins from soy flour samples | Intact Proteins | SEC-RPLC-UV-vis (N,S) | Nardiello et al. (2020) |
| Monoclonal antibodies | Biopharma | Affinity-SEC-UV-vis (N,S) | Wang et al. (2020) |
| TCM (Lonicerae Japonicae Flos) | Natural medicines | HILIC×RPLC-MS (F,M) | Pan et al. (2020) |
| Metabolites in Brassica juncea Cultivars | Metabolites | RPLC×RPLC-UV-vis (N,P) | Arena et al. (2020) |
| Synthetic polymers (linear low-density polyethylene resins) | Polymers | NPLC×SEC-ELSD (N,P) | Sigwinta et al. (2020) |
| TCM (Buddleja davidii) | Natural medicines | RPLC×HILIC-MS (N,O) | Chen et al. (2020) |
| Monoclonal antibodies | Biopharma | AEX-SEC-UV-vis (N,P) | Chen et al. (2020) |
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||
| -- (F,O) | () | ||